{"recordsFiltered":48671,"recordsTotal":48671,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-registry_id&start=41400","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-registry_id&start=40800","results":[{"registry_id":"NCT07450586","publication_url":"https://clinicaltrials.gov/study/NCT07450586","title":"Virtual Activities of Living for Occupational Rehabilitation (VALOR)","has_exemption":false,"start_date":"2026-06-15","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Barron Associates, Inc.","sponsor_slug":"barron-associates-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04563520","publication_url":"https://clinicaltrials.gov/study/NCT04563520","title":"aPCC and Emicizumab Safety Study in Congenital Hemophilia A Patients With Inhibitors (SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07219797","publication_url":"https://clinicaltrials.gov/study/NCT07219797","title":"Study of Monochromatic X-ray Mammography System","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Imagine Scientific, Inc.","sponsor_slug":"imagine-scientific-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07453563","publication_url":"https://clinicaltrials.gov/study/NCT07453563","title":"Comparison of GlideScope and Airway Scope for Intubating Morbidly Obese Patients: A Randomized Controlled Study","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of New Mexico","sponsor_slug":"university-of-new-mexico","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07460323","publication_url":"https://clinicaltrials.gov/study/NCT07460323","title":"Study of TRE Seals on Early Post-operative Subjects","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Hollister Incorporated","sponsor_slug":"hollister-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07461935","publication_url":"https://clinicaltrials.gov/study/NCT07461935","title":"Early Feasibility Study of the Single Chamber ALPS Leadless Pacemaker System in Patients With Bradycardia","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Cairdac SA","sponsor_slug":"cairdac-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07516106","publication_url":"https://clinicaltrials.gov/study/NCT07516106","title":"Prospective Multi-center Study Comparing Pulsed Tm:YAG Laser to Pulse Modulated Holmium Laser in the Treatment of Nephrolithiasis With Flexible And Navigable Ureteric Access Sheath (FANS)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06443177","publication_url":"https://clinicaltrials.gov/study/NCT06443177","title":"The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid Hemorrhage","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07408557","publication_url":"https://clinicaltrials.gov/study/NCT07408557","title":"Adapting the Stanford Obstetric Recovery Checklist (STORK) to a Digital Health Platform: A Feasibility and User Feedback Study","has_exemption":false,"start_date":"2026-07-31","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05106127","publication_url":"https://clinicaltrials.gov/study/NCT05106127","title":"A Phase 2, Open-Label, Safety Lead-In With Long Term Safety Study of EG-007, Added to the Combination of Lenvatinib Plus Pembrolizumab","has_exemption":false,"start_date":"2026-08-31","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Evergreen Therapeutics, Inc.","sponsor_slug":"evergreen-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04777500","publication_url":"https://clinicaltrials.gov/study/NCT04777500","title":"Applying Transcutaneous Auricular Vagus Nerve Stimulation to Treat Fibromyalgia","has_exemption":false,"start_date":"2026-10-03","completion_date":"2027-03-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02046330","publication_url":"https://clinicaltrials.gov/study/NCT02046330","title":"Deep Brain Stimulation (DBS) Therapy for Treatment Resistant","has_exemption":false,"start_date":"2013-12-16","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01953588","publication_url":"https://clinicaltrials.gov/study/NCT01953588","title":"Alternate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women: A Phase III Study","has_exemption":false,"start_date":"2014-02-27","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02231775","publication_url":"https://clinicaltrials.gov/study/NCT02231775","title":"Neoadjuvant and Adjuvant Dabrafenib and Trametinib in Patients With Clinical Stage III Melanoma (Combi-Neo)","has_exemption":false,"start_date":"2014-10-22","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02484248","publication_url":"https://clinicaltrials.gov/study/NCT02484248","title":"Double-blind, Placebo-controlled, Cross-over Trial of Ketotifen in Children and Adolescents With Functional Dyspepsia in Association With Duodenal Eosinophilia","has_exemption":false,"start_date":"2015-08-31","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Craig A. Friesen, MD","sponsor_slug":"craig-a-friesen-md","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03410043","publication_url":"https://clinicaltrials.gov/study/NCT03410043","title":"Randomized Phase II Trial of Osimertinib With or Without Local Consolidation Therapy (LCT) for Patients With EGFR-Mutant Metastatic NSCLC (NORTHSTAR)","has_exemption":false,"start_date":"2018-01-17","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03574571","publication_url":"https://clinicaltrials.gov/study/NCT03574571","title":"Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)","has_exemption":false,"start_date":"2018-06-19","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04263025","publication_url":"https://clinicaltrials.gov/study/NCT04263025","title":"Prospective, Controlled Study Evaluating Recovery of Potency and Continence Following Robot-Assisted Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft","has_exemption":false,"start_date":"2020-01-30","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Hackensack Meridian Health","sponsor_slug":"hackensack-meridian-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04332874","publication_url":"https://clinicaltrials.gov/study/NCT04332874","title":"A Phase II Study of Concurrent Systemic Pembrolizumab and Isolated Limb Infusion (ILI) With Melphalan and Dactinomycin for Patients With Locally Advanced or Metastatic Extremity Sarcoma","has_exemption":false,"start_date":"2020-04-01","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04468061","publication_url":"https://clinicaltrials.gov/study/NCT04468061","title":"Saci-IO TNBC: Randomized Phase II Study of Sacituzumab Govitecan With or Without Pembrolizumab in PD-L1-negative Metastatic Triple Negative Breast Cancer (TNBC)","has_exemption":false,"start_date":"2020-07-20","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04422652","publication_url":"https://clinicaltrials.gov/study/NCT04422652","title":"Combination of Novel Therapies for CKD Comorbid Depression (CONCORD)","has_exemption":false,"start_date":"2020-09-24","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Stony Brook University","sponsor_slug":"stony-brook-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04735263","publication_url":"https://clinicaltrials.gov/study/NCT04735263","title":"Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD","has_exemption":false,"start_date":"2021-02-04","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts Eye and Ear Infirmary","sponsor_slug":"massachusetts-eye-and-ear-infirmary","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04693377","publication_url":"https://clinicaltrials.gov/study/NCT04693377","title":"Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases","has_exemption":false,"start_date":"2021-03-16","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04701684","publication_url":"https://clinicaltrials.gov/study/NCT04701684","title":"WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)","has_exemption":false,"start_date":"2021-06-23","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Philips Clinical & Medical Affairs Global","sponsor_slug":"philips-clinical-medical-affairs-global","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05108818","publication_url":"https://clinicaltrials.gov/study/NCT05108818","title":"Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults","has_exemption":false,"start_date":"2021-10-07","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04939090","publication_url":"https://clinicaltrials.gov/study/NCT04939090","title":"A Randomized Phase III Trial of Olanzapine Versus Megestrol Acetate for Cancer-Associated Anorexia","has_exemption":false,"start_date":"2022-01-03","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04835129","publication_url":"https://clinicaltrials.gov/study/NCT04835129","title":"A Multisite, Phase II Study of Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma","has_exemption":false,"start_date":"2022-01-10","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04859946","publication_url":"https://clinicaltrials.gov/study/NCT04859946","title":"Itacitinib to Prevent Graft Versus Host Disease","has_exemption":false,"start_date":"2022-01-11","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05319509","publication_url":"https://clinicaltrials.gov/study/NCT05319509","title":"Pilot Study of Virtual Reality Therapy for Students With Anxiety","has_exemption":false,"start_date":"2022-04-01","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05271240","publication_url":"https://clinicaltrials.gov/study/NCT05271240","title":"A Phase III Randomized Trial of Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab (Avastin) With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed Glioblastoma (GBM)","has_exemption":false,"start_date":"2022-04-27","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05046353","publication_url":"https://clinicaltrials.gov/study/NCT05046353","title":"D-serine Augmentation of Neuroplasticity-based Auditory Learning in Schizophrenia: R33 Phase","has_exemption":false,"start_date":"2022-12-01","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"New York State Psychiatric Institute","sponsor_slug":"new-york-state-psychiatric-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05919264","publication_url":"https://clinicaltrials.gov/study/NCT05919264","title":"A Phase 1/2 Study of FOG-001 in Participants With Locally Advanced or Metastatic Solid Tumors","has_exemption":false,"start_date":"2023-05-23","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Parabilis Medicines, Inc.","sponsor_slug":"parabilis-medicines-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05303792","publication_url":"https://clinicaltrials.gov/study/NCT05303792","title":"A Randomized Phase II Study Comparing Inotuzumab Plus Chemotherapy Versus Standard Chemotherapy in Older Adults With Philadelphia-Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia","has_exemption":false,"start_date":"2023-06-09","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05547048","publication_url":"https://clinicaltrials.gov/study/NCT05547048","title":"Integrated eHealth for HIV and Substance Use Disorders in Justice Involved Women","has_exemption":false,"start_date":"2023-07-25","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05593055","publication_url":"https://clinicaltrials.gov/study/NCT05593055","title":"Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension","has_exemption":false,"start_date":"2023-08-25","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06027788","publication_url":"https://clinicaltrials.gov/study/NCT06027788","title":"Embolic Protection in Patients Undergoing High-Risk Valve Surgery","has_exemption":false,"start_date":"2023-09-18","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05501704","publication_url":"https://clinicaltrials.gov/study/NCT05501704","title":"ETHAN: A Phase II Study Comparing Different Endocrine THerapies for mAle Breast caNcer","has_exemption":false,"start_date":"2023-10-11","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Jose Pablo Leone","sponsor_slug":"jose-pablo-leone","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06144645","publication_url":"https://clinicaltrials.gov/study/NCT06144645","title":"A Phase 3, Randomized, Double-Blind, Dose-Ranging Evaluation of Transcutaneous Vagus Nerve Stimulation (tVNS) to Reduce Temper Outbursts in People With Prader-Willi Syndrome (PWS)","has_exemption":false,"start_date":"2024-01-08","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Foundation for Prader-Willi Research","sponsor_slug":"foundation-for-prader-willi-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06116526","publication_url":"https://clinicaltrials.gov/study/NCT06116526","title":"Dupilumab De-escalation in Pediatric Atopic Dermatitis: A Pilot Trial","has_exemption":false,"start_date":"2024-04-01","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06320405","publication_url":"https://clinicaltrials.gov/study/NCT06320405","title":"A Phase Ib/II Study of Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2024-05-21","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"OHSU Knight Cancer Institute","sponsor_slug":"ohsu-knight-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06383572","publication_url":"https://clinicaltrials.gov/study/NCT06383572","title":"Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies","has_exemption":false,"start_date":"2024-06-26","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06258447","publication_url":"https://clinicaltrials.gov/study/NCT06258447","title":"Randomized Controlled Pivotal Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients With Ischemic Heart Failure II Trial","has_exemption":false,"start_date":"2024-08-01","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"BioCardia, Inc.","sponsor_slug":"biocardia-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06655376","publication_url":"https://clinicaltrials.gov/study/NCT06655376","title":"Delayed ARIES: Aspirin and Hemocompatibility Events in Advanced Heart Failure Patients Chronically Supported With a Left Ventricular Assist Device","has_exemption":false,"start_date":"2024-10-02","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05519111","publication_url":"https://clinicaltrials.gov/study/NCT05519111","title":"Dronabinol for the Reduction of Chronic Pain and Inflammation in People With Sickle Cell Disease","has_exemption":false,"start_date":"2025-04-03","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06868628","publication_url":"https://clinicaltrials.gov/study/NCT06868628","title":"A Phase 2a Study to Evaluate Microglial Activation, Safety, and Clinical Effects of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)","has_exemption":false,"start_date":"2025-05-19","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Tiziana Life Sciences LTD","sponsor_slug":"tiziana-life-sciences-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06972628","publication_url":"https://clinicaltrials.gov/study/NCT06972628","title":"177Lu-PSMA-617 (Pluvicto) for the Treatment of Patients With Progressive PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Super Scan Bone Scan","has_exemption":false,"start_date":"2025-05-23","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Ebrahim S Delpassand","sponsor_slug":"ebrahim-s-delpassand","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07049952","publication_url":"https://clinicaltrials.gov/study/NCT07049952","title":"BabyStrong II (Stimulating the Tragus for Neural Growth): A Randomized Controlled Trial of taVNS-Paired Bottle Feeding to Improve Oral Feeding","has_exemption":false,"start_date":"2025-11-16","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07296328","publication_url":"https://clinicaltrials.gov/study/NCT07296328","title":"Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter","has_exemption":false,"start_date":"2026-01-15","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07339072","publication_url":"https://clinicaltrials.gov/study/NCT07339072","title":"Temporal Interference Methods for Non-invasive Deep Brain Stimulation","has_exemption":false,"start_date":"2026-02-03","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06811324","publication_url":"https://clinicaltrials.gov/study/NCT06811324","title":"The Effects of Tirzepatide Use on Muscle and Vascular Function Among Obese Older Adults","has_exemption":false,"start_date":"2026-04-01","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07342452","publication_url":"https://clinicaltrials.gov/study/NCT07342452","title":"A Prospective Pilot Study Comparing Immediate Combination Versus Sequential Treatment Using Injectable Poly-L-lactic Acid and Synchronous Ultrasound Parallel Beam Technology","has_exemption":false,"start_date":"2026-04-01","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07422532","publication_url":"https://clinicaltrials.gov/study/NCT07422532","title":"An Open-label, Multi-centre, Randomised Controlled Trial to Assess the Efficacy, Safety and Utility of Automated Insulin Delivery in People With Type 2 Diabetes and Sub-optimal Glycaemia Undergoing Haemodialysis","has_exemption":false,"start_date":"2026-04-01","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Imperial College London","sponsor_slug":"imperial-college-london","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07497737","publication_url":"https://clinicaltrials.gov/study/NCT07497737","title":"Osteopathic Manipulative Treatment as an Adjunct Therapy for Adhesive Capsulitis","has_exemption":false,"start_date":"2026-04-01","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"University Hospitals Cleveland Medical Center","sponsor_slug":"university-hospitals-cleveland-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06969287","publication_url":"https://clinicaltrials.gov/study/NCT06969287","title":"Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery (MD FluNCS)","has_exemption":false,"start_date":"2026-04-06","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07534722","publication_url":"https://clinicaltrials.gov/study/NCT07534722","title":"Transcutaneous Auricular Vagus Nerve Stimulation for Attenuation of Inflammatory Response and Blood Pressure in Type B Aortic Dissection","has_exemption":false,"start_date":"2026-04-17","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221383","publication_url":"https://clinicaltrials.gov/study/NCT07221383","title":"A Pilot Randomized Controlled Trial of LDART, a Social Support Intervention for Alcohol Use Disorder","has_exemption":false,"start_date":"2026-04-29","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221396","publication_url":"https://clinicaltrials.gov/study/NCT07221396","title":"Pilot Study of the Digital Intervention LDART for Stimulant Use Disorder","has_exemption":false,"start_date":"2026-04-29","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07136363","publication_url":"https://clinicaltrials.gov/study/NCT07136363","title":"RESTORE Study R61 Pilot Phase: Recovery and Engagement for Stimulant Users on Re-entry","has_exemption":false,"start_date":"2026-06-01","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05509842","publication_url":"https://clinicaltrials.gov/study/NCT05509842","title":"High-dose Accelerated Theta Burst Stimulation to Restore PD-induced Motor Network Dysconnectivity","has_exemption":false,"start_date":"2026-09-01","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06606561","publication_url":"https://clinicaltrials.gov/study/NCT06606561","title":"A Phase I/II Randomized, Double Blinded, Placebo Controlled Trial to Evaluate the Safety and Potential Efficacy of NANOVAE Injected Intra-Articular in Patients Suffering With Knee Osteoarthritis","has_exemption":false,"start_date":"2026-10-01","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"Nova Vita Laboratory","sponsor_slug":"nova-vita-laboratory","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06649604","publication_url":"https://clinicaltrials.gov/study/NCT06649604","title":"Alleviating Panretinal Photocoagulation Associated Ocular Pain With Vibratory Stimulation","has_exemption":false,"start_date":"2026-10-15","completion_date":"2027-04-01","has_results":false,"results_due":false,"sponsor_name":"University of Alberta","sponsor_slug":"university-of-alberta","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04449549","publication_url":"https://clinicaltrials.gov/study/NCT04449549","title":"Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel","has_exemption":false,"start_date":"2020-08-24","completion_date":"2027-04-02","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06334523","publication_url":"https://clinicaltrials.gov/study/NCT06334523","title":"Open Randomised Study of Conventional Ventilation Optimised by Dead Space Washout in Extremely Premature Infants","has_exemption":false,"start_date":"2025-02-13","completion_date":"2027-04-02","has_results":false,"results_due":false,"sponsor_name":"Centre Hospitalier Intercommunal Creteil","sponsor_slug":"centre-hospitalier-intercommunal-creteil","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05374278","publication_url":"https://clinicaltrials.gov/study/NCT05374278","title":"First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in the Brains of Healthy Controls and Patients With Dementia.","has_exemption":false,"start_date":"2021-11-02","completion_date":"2027-04-03","has_results":false,"results_due":false,"sponsor_name":"David Wilson","sponsor_slug":"david-wilson","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05730816","publication_url":"https://clinicaltrials.gov/study/NCT05730816","title":"MAGIC-AKI: Magnesium for the Prevention of Hyperthermic Intraoperative Cisplatin-Associated AKI","has_exemption":false,"start_date":"2023-04-04","completion_date":"2027-04-03","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07443254","publication_url":"https://clinicaltrials.gov/study/NCT07443254","title":"Prospective Single-Arm Feasibility Study of IR-led Deep Sedation for Interventional Radiology Procedures Traditionally Performed With Anesthesiology Support","has_exemption":false,"start_date":"2026-03-02","completion_date":"2027-04-03","has_results":false,"results_due":false,"sponsor_name":"CAMC Health System","sponsor_slug":"camc-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03107416","publication_url":"https://clinicaltrials.gov/study/NCT03107416","title":"Phase I/II Study of Transarterial Hepatic Embolization With Bumetanide in Unresectable Hepatocellular Carcinoma","has_exemption":false,"start_date":"2017-04-05","completion_date":"2027-04-05","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03319667","publication_url":"https://clinicaltrials.gov/study/NCT03319667","title":"A Phase 3 Randomized, Open-label, Multicenter Study Assessing the Clinical Benefit of Isatuximab (SAR650984) in Combination With Bortezomib (Velcade®), Lenalidomide and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant","has_exemption":false,"start_date":"2017-12-07","completion_date":"2027-04-05","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07528742","publication_url":"https://clinicaltrials.gov/study/NCT07528742","title":"Enhancing Reaction Time Through Non-Invasive Vagus Nerve Stimulation","has_exemption":false,"start_date":"2026-04-06","completion_date":"2027-04-05","has_results":false,"results_due":false,"sponsor_name":"Youngstown State University","sponsor_slug":"youngstown-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07487948","publication_url":"https://clinicaltrials.gov/study/NCT07487948","title":"A Pilot Study to Assess Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris","has_exemption":false,"start_date":"2026-05-04","completion_date":"2027-04-05","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04015141","publication_url":"https://clinicaltrials.gov/study/NCT04015141","title":"An Open-Label Study With Extension Phase to Evaluate the Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Subjects (Age 1 Month to Less Than 18 Years) With Childhood Epilepsy","has_exemption":false,"start_date":"2019-05-31","completion_date":"2027-04-06","has_results":false,"results_due":false,"sponsor_name":"Eisai Inc.","sponsor_slug":"eisai-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04421963","publication_url":"https://clinicaltrials.gov/study/NCT04421963","title":"Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib and Are Judged by the Investigator to Clinically Benefit From Continued Treatment","has_exemption":false,"start_date":"2020-08-04","completion_date":"2027-04-06","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05434234","publication_url":"https://clinicaltrials.gov/study/NCT05434234","title":"A Phase 1A/1B, Multicenter, Nonrandomized, Open-Label, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of YL201 as a Single Agent and in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2022-05-25","completion_date":"2027-04-06","has_results":false,"results_due":false,"sponsor_name":"MediLink Therapeutics (Suzhou) Co., Ltd.","sponsor_slug":"medilink-therapeutics-suzhou-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05331183","publication_url":"https://clinicaltrials.gov/study/NCT05331183","title":"A Phase 3 Open-label Study Evaluating the Long-term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects With Non-F508del CFTR Genotypes","has_exemption":false,"start_date":"2022-11-23","completion_date":"2027-04-06","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07231419","publication_url":"https://clinicaltrials.gov/study/NCT07231419","title":"A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of the Efficacy and Safety of Suzetrigine in Subjects With Pain Associated With Diabetic Peripheral Neuropathy","has_exemption":false,"start_date":"2025-11-21","completion_date":"2027-04-06","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03930953","publication_url":"https://clinicaltrials.gov/study/NCT03930953","title":"A Phase 1/2, Multi-center, Open-label Study to Assess the Safety, Pharmacokinetics, and Preliminary Efficacy of an Orally Available Small Molecule, CC-99282, Alone and in Combination With Anti-Lymphoma Agents in Subjects With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL).","has_exemption":false,"start_date":"2019-05-20","completion_date":"2027-04-07","has_results":false,"results_due":false,"sponsor_name":"Celgene","sponsor_slug":"celgene","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04028063","publication_url":"https://clinicaltrials.gov/study/NCT04028063","title":"An Open-Label, Phase II Efficacy Trial of Doxorubicin in Combination With Dual Checkpoint Blockade Using Zalifrelimab (AGEN1884) or Botensilimab (AGEN1181) With Balstilimab (AGEN2034) for Advanced or Metastatic Soft Tissue Sarcomas","has_exemption":false,"start_date":"2020-01-28","completion_date":"2027-04-07","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03651128","publication_url":"https://clinicaltrials.gov/study/NCT03651128","title":"A Phase 3, Multicenter, Randomized, Open-label Study to Compare the Efficacy and Safety of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM) (KarMMa-3)","has_exemption":false,"start_date":"2019-04-16","completion_date":"2027-04-08","has_results":false,"results_due":false,"sponsor_name":"Celgene","sponsor_slug":"celgene","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04317534","publication_url":"https://clinicaltrials.gov/study/NCT04317534","title":"A Randomized Phase II Trial of Adjuvant Pembrolizumab Versus Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm: Big Ten Cancer Research Consortium BTCRC-LUN18-153","has_exemption":false,"start_date":"2020-05-05","completion_date":"2027-04-08","has_results":false,"results_due":false,"sponsor_name":"Greg Durm, MD","sponsor_slug":"greg-durm-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07156175","publication_url":"https://clinicaltrials.gov/study/NCT07156175","title":"A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of SAR444336 in Participants With Microscopic Colitis in Clinical Remission With Budesonide","has_exemption":false,"start_date":"2025-10-14","completion_date":"2027-04-08","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05286788","publication_url":"https://clinicaltrials.gov/study/NCT05286788","title":"Phase 2 Study of the MEK Inhibitor MEKTOVI® (Binimetinib) for the Treatment of Pediatric Adamantinomatous Craniopharyngioma","has_exemption":false,"start_date":"2023-04-10","completion_date":"2027-04-10","has_results":false,"results_due":false,"sponsor_name":"Nationwide Children's Hospital","sponsor_slug":"nationwide-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06734195","publication_url":"https://clinicaltrials.gov/study/NCT06734195","title":"Comparing the Synergistic Effect of Caudal Dexmedetomidine and Propofol Versus Caudal Dexmedetomidine Only or Propofol Only in Prevention of Sevoflurane Related Emergence Agitation in Pediatric Patients Undergoing Congenital Inguinal Hernia Repair: Randomized Double-blind Controlled Study","has_exemption":false,"start_date":"2024-12-20","completion_date":"2027-04-10","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05669664","publication_url":"https://clinicaltrials.gov/study/NCT05669664","title":"A Phase 2 Study of Darolutamide in Combination With Leuprolide Acetate in Hormone-Therapy Naive Recurrent and/or Metastatic Androgen Receptor (AR) Positive Salivary Gland Cancer","has_exemption":false,"start_date":"2023-07-20","completion_date":"2027-04-11","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06666790","publication_url":"https://clinicaltrials.gov/study/NCT06666790","title":"DermaSensor Postmarket Surveillance Study","has_exemption":false,"start_date":"2024-10-08","completion_date":"2027-04-11","has_results":false,"results_due":false,"sponsor_name":"DermaSensor, Inc.","sponsor_slug":"dermasensor-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07136688","publication_url":"https://clinicaltrials.gov/study/NCT07136688","title":"A Randomized Control Trial of Transcutaneous Tibial Nerve Stimulation for Neurogenic Bladder in the Pediatric Population","has_exemption":false,"start_date":"2026-03-27","completion_date":"2027-04-11","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05624749","publication_url":"https://clinicaltrials.gov/study/NCT05624749","title":"A Randomized, Double-blind, Placebo-controlled Multicenter Phase 3 Study to Evaluate Efficacy, Safety and Tolerability of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)","has_exemption":false,"start_date":"2023-04-21","completion_date":"2027-04-12","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05090371","publication_url":"https://clinicaltrials.gov/study/NCT05090371","title":"A Randomized, Open Label, Multi-center, Active-comparator Study to Assess Efficacy, Safety & Tolerability of Ofatumumab 20mg sc Monthly Versus Continued Current Therapy in Relapsing-remitting Multiple Sclerosis After Elevation of Serum Neurofilament Light Levels (SOSTOS)","has_exemption":false,"start_date":"2022-03-02","completion_date":"2027-04-13","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05549258","publication_url":"https://clinicaltrials.gov/study/NCT05549258","title":"An Open-Label Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder","has_exemption":false,"start_date":"2023-07-03","completion_date":"2027-04-13","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06765642","publication_url":"https://clinicaltrials.gov/study/NCT06765642","title":"Evaluation of 3 Patterned rTMS Stimulation Dosage on Corticospinal Excitability and Motor Learning in Stroke Patients","has_exemption":false,"start_date":"2025-06-09","completion_date":"2027-04-13","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06954805","publication_url":"https://clinicaltrials.gov/study/NCT06954805","title":"Defining the Role of ctDNA Monitoring in a Risk Stratified Clinical Trial for Posttransplant Lymphoproliferative Disorder (PTLD)","has_exemption":false,"start_date":"2025-04-14","completion_date":"2027-04-14","has_results":false,"results_due":false,"sponsor_name":"Jennifer Amengual","sponsor_slug":"jennifer-amengual","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06815497","publication_url":"https://clinicaltrials.gov/study/NCT06815497","title":"Phase II Non-Randomized, Unblinded, Single-Center Trial of Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer Versus Historical Best Supportive Care","has_exemption":false,"start_date":"2026-01-21","completion_date":"2027-04-14","has_results":false,"results_due":false,"sponsor_name":"Tyler J Curiel","sponsor_slug":"tyler-j-curiel","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04195633","publication_url":"https://clinicaltrials.gov/study/NCT04195633","title":"Hematopoietic Stem Cell Transplantation From Haploidentical Donors in Patients With Hematological Malignancies Using a Treosulfan-Based Preparative Regimen","has_exemption":false,"start_date":"2021-01-25","completion_date":"2027-04-15","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05472792","publication_url":"https://clinicaltrials.gov/study/NCT05472792","title":"Comparison of Adjuvant Monotherapy With Endocrine Therapy or Accelerated Partial Breast Irradiation Following Lumpectomy for Low Risk Breast Cancer Patients Over 65 (CAMERAN)","has_exemption":false,"start_date":"2022-05-17","completion_date":"2027-04-15","has_results":false,"results_due":false,"sponsor_name":"UNC Lineberger Comprehensive Cancer Center","sponsor_slug":"unc-lineberger-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06493019","publication_url":"https://clinicaltrials.gov/study/NCT06493019","title":"A Phase II Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer","has_exemption":false,"start_date":"2024-09-30","completion_date":"2027-04-15","has_results":false,"results_due":false,"sponsor_name":"Dustin Deming","sponsor_slug":"dustin-deming","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05602779","publication_url":"https://clinicaltrials.gov/study/NCT05602779","title":"Leveraging Noninvasive Transcutaneous Vagus Nerve Stimulation and Smartphone Technology to Reduce Suicidal Behaviors and Suicide Among Highly Vulnerable Adolescents","has_exemption":false,"start_date":"2024-11-15","completion_date":"2027-04-15","has_results":false,"results_due":false,"sponsor_name":"University of Notre Dame","sponsor_slug":"university-of-notre-dame","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06691893","publication_url":"https://clinicaltrials.gov/study/NCT06691893","title":"A Randomized Controlled Trial to Evaluate the Efficacy of Immobilized Lipase (RELiZORB) During Enteral Nutrition in Patients With Exocrine Pancreatic Insufficiency Secondary to Acute Pancreatitis","has_exemption":false,"start_date":"2025-03-28","completion_date":"2027-04-15","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05553353","publication_url":"https://clinicaltrials.gov/study/NCT05553353","title":"Evaluating a Novel Method to Determine the rTMS Dose Needed for Treating Depression After Spinal Cord Injury","has_exemption":false,"start_date":"2025-03-31","completion_date":"2027-04-15","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06633900","publication_url":"https://clinicaltrials.gov/study/NCT06633900","title":"Extended-Release Naltrexone as Opioid Overdose Pre-Exposure Prophylaxis (PrEP) in People Using Stimulants Living With or At Risk of HIV","has_exemption":false,"start_date":"2025-04-10","completion_date":"2027-04-15","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06271707","publication_url":"https://clinicaltrials.gov/study/NCT06271707","title":"Left Sided Stellate Ganglion Blocks Impact on the Rate of Post-operative Atrial Fibrillation in Patients Undergoing Thoracic Surgery: A Pilot Study","has_exemption":false,"start_date":"2025-05-19","completion_date":"2027-04-15","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06934200","publication_url":"https://clinicaltrials.gov/study/NCT06934200","title":"Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels","has_exemption":false,"start_date":"2025-05-19","completion_date":"2027-04-15","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06706362","publication_url":"https://clinicaltrials.gov/study/NCT06706362","title":"Assessing the Utility of Prophylactic Antibiotics at Time of Urethral Bulking Using Bulkamid","has_exemption":false,"start_date":"2025-09-15","completion_date":"2027-04-15","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06364904","publication_url":"https://clinicaltrials.gov/study/NCT06364904","title":"A Multicenter, III Stage, Randomized Controlled Trail on the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib in Untreated Unresectable and Metastatic Urothelial Carcinoma.","has_exemption":false,"start_date":"2025-10-31","completion_date":"2027-04-15","has_results":false,"results_due":false,"sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","sponsor_slug":"sun-yat-sen-memorial-hospital-of-sun-yat-sen-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07409103","publication_url":"https://clinicaltrials.gov/study/NCT07409103","title":"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Investigate the Safety and Efficacy of ELV001 as Add-on Therapy in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)","has_exemption":false,"start_date":"2026-02-18","completion_date":"2027-04-15","has_results":false,"results_due":false,"sponsor_name":"Elevara Medicines Limited","sponsor_slug":"elevara-medicines-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07228845","publication_url":"https://clinicaltrials.gov/study/NCT07228845","title":"Effectiveness Comparison of 3D-Printed and Conventional Ear Tip Comfort in Individuals With Hearing Loss","has_exemption":false,"start_date":"2026-03-15","completion_date":"2027-04-15","has_results":false,"results_due":false,"sponsor_name":"University of Arizona","sponsor_slug":"university-of-arizona","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03839771","publication_url":"https://clinicaltrials.gov/study/NCT03839771","title":"A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy.","has_exemption":false,"start_date":"2019-03-01","completion_date":"2027-04-17","has_results":false,"results_due":false,"sponsor_name":"Stichting Hemato-Oncologie voor Volwassenen Nederland","sponsor_slug":"stichting-hemato-oncologie-voor-volwassenen-nederland","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07137598","publication_url":"https://clinicaltrials.gov/study/NCT07137598","title":"A Phase II, Multicenter, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have an Inadequate Response or Intolerance to TNF and/or JAK Inhibitors","has_exemption":false,"start_date":"2025-12-05","completion_date":"2027-04-17","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06090903","publication_url":"https://clinicaltrials.gov/study/NCT06090903","title":"Exploration Into the Association Between Decorin (DCN) Expression and MR Phenotypes in GBM","has_exemption":false,"start_date":"2022-04-14","completion_date":"2027-04-18","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06427395","publication_url":"https://clinicaltrials.gov/study/NCT06427395","title":"A Multicenter, Open-Label, Extension Clinical Trial to Evaluate Safety and Efficacy of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis (PBC)","has_exemption":false,"start_date":"2024-07-16","completion_date":"2027-04-18","has_results":false,"results_due":false,"sponsor_name":"Zydus Therapeutics Inc.","sponsor_slug":"zydus-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05774951","publication_url":"https://clinicaltrials.gov/study/NCT05774951","title":"CAMBRIA-1: A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Extended Therapy With Camizestrant (AZD9833, a Next Generation, Oral Selective Estrogen Receptor Degrader) Versus Standard Endocrine Therapy (Aromatase Inhibitor or Tamoxifen) in Patients With ER+/HER2- Early Breast Cancer and an Intermediate or High Risk of Recurrence Who Have Completed Definitive Locoregional Therapy and at Least 2 Years of Standard Adjuvant Endocrine-Based Therapy Without Disease Recurrence","has_exemption":false,"start_date":"2023-03-31","completion_date":"2027-04-20","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07029711","publication_url":"https://clinicaltrials.gov/study/NCT07029711","title":"A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF RITLECITINIB IN PEDIATRIC PARTICIPANTS 6 TO LESS THAN 12 YEARS OF AGE WITH SEVERE ALOPECIA AREATA","has_exemption":false,"start_date":"2025-07-31","completion_date":"2027-04-20","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07285213","publication_url":"https://clinicaltrials.gov/study/NCT07285213","title":"A Phase IIb, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AZD5148 for Prevention of Recurrence of Clostridioides Difficile Infection in Individuals 18 Years of Age and Above","has_exemption":false,"start_date":"2025-12-10","completion_date":"2027-04-20","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07285785","publication_url":"https://clinicaltrials.gov/study/NCT07285785","title":"A Randomized, Open-Label Study to Assess Pharmacokinetics of Xifaxan® 200 mg in Pediatric Subjects 6 to 11 Years of Age With Acute Diarrhea of Suspected Bacterial Etiology, and the Safety and Efficacy of Xifaxan® 200 mg Plus Oral Rehydration Therapy (ORT) Compared to ORT Alone","has_exemption":false,"start_date":"2026-02-11","completion_date":"2027-04-20","has_results":false,"results_due":false,"sponsor_name":"Bausch Health Americas, Inc.","sponsor_slug":"bausch-health-americas-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04031677","publication_url":"https://clinicaltrials.gov/study/NCT04031677","title":"A Randomized Phase III Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients With High Risk RetroPeritoneal Sarcoma (RPS)","has_exemption":false,"start_date":"2021-01-20","completion_date":"2027-04-21","has_results":false,"results_due":false,"sponsor_name":"European Organisation for Research and Treatment of Cancer - EORTC","sponsor_slug":"european-organisation-for-research-and-treatment-of-cancer-eortc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06497504","publication_url":"https://clinicaltrials.gov/study/NCT06497504","title":"A Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Assess the Efficacy and Safety of Treatment With Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection on Antiretroviral Treatment","has_exemption":false,"start_date":"2024-09-17","completion_date":"2027-04-22","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06713668","publication_url":"https://clinicaltrials.gov/study/NCT06713668","title":"Augmented Pacing for Shock in the Cardiac Intensive Care Unit - A Pilot Patient-level Crossover Trial","has_exemption":false,"start_date":"2025-04-22","completion_date":"2027-04-22","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07467993","publication_url":"https://clinicaltrials.gov/study/NCT07467993","title":"A Phase 2a, Randomized, Participant- and Investigator- Blinded, Parallel-group, Placebo-controlled, Multicenter Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With DSM-5 Schizophrenia (STAR-1)","has_exemption":false,"start_date":"2026-03-16","completion_date":"2027-04-22","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06305767","publication_url":"https://clinicaltrials.gov/study/NCT06305767","title":"A Phase 1/2 Study of V940 Plus Pembrolizumab With or Without Enfortumab Vedotin in Muscle-Invasive Urothelial Carcinoma (MIUC) (INTerpath-005)","has_exemption":false,"start_date":"2024-03-28","completion_date":"2027-04-23","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06242834","publication_url":"https://clinicaltrials.gov/study/NCT06242834","title":"Phase II, Single Arm, Open Label, Study of the Combination of Pembrolizumab and Tazemetostat to Overcome Immune Tolerance Following ASCT or CAR T-Cell Therapy in Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma","has_exemption":false,"start_date":"2024-09-30","completion_date":"2027-04-24","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04929392","publication_url":"https://clinicaltrials.gov/study/NCT04929392","title":"A Phase 2 Trial of Neoadjuvant Chemoradiation With Pembrolizumab Followed by Pembrolizumab With Lenvatinib in Esophageal/Gastroesophageal Junction Squamous Cell and Adenocarcinomas","has_exemption":false,"start_date":"2022-01-25","completion_date":"2027-04-25","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06462235","publication_url":"https://clinicaltrials.gov/study/NCT06462235","title":"A PHASE 2A, 2-PART, OPEN-LABEL, NON-RANDOMIZED, MULTICENTER, SINGLE AND MULTIPLE DOSE TRIAL TO EVALUATE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF AZTREONAM AND AVIBACTAM ± METRONIDAZOLE IN NEONATES AND INFANTS FROM BIRTH TO LESS THAN 9 MONTHS OF AGE WITH SUSPECTED OR CONFIRMED INFECTIONS DUE TO GRAM-NEGATIVE PATHOGENS REQUIRING INTRAVENOUS ANTIBIOTIC TREATMENT","has_exemption":false,"start_date":"2024-09-25","completion_date":"2027-04-25","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06731075","publication_url":"https://clinicaltrials.gov/study/NCT06731075","title":"A Double-Blinded, Placebo-controlled, Double Dummy, Multi-center Randomized, Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on One to Three Glucose-lowering Agents","has_exemption":false,"start_date":"2025-12-15","completion_date":"2027-04-25","has_results":false,"results_due":false,"sponsor_name":"Oramed, Ltd.","sponsor_slug":"oramed-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07445919","publication_url":"https://clinicaltrials.gov/study/NCT07445919","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Clinical Study to Evaluate the Efficacy and Safety of SM17 Monoclonal Antibody Injection (Subcutaneous Injection) in Participants With Moderate to Severe Atopic Dermatitis","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-04-25","has_results":false,"results_due":false,"sponsor_name":"SinoMab BioScience Ltd","sponsor_slug":"sinomab-bioscience-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07340671","publication_url":"https://clinicaltrials.gov/study/NCT07340671","title":"Evaluating the Efficacy of the 1726nm Laser for the Treatment of Facial Papules in Frontal Fibrosing Alopecia (FFA)","has_exemption":false,"start_date":"2026-04-27","completion_date":"2027-04-26","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04959175","publication_url":"https://clinicaltrials.gov/study/NCT04959175","title":"Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies","has_exemption":false,"start_date":"2021-09-23","completion_date":"2027-04-27","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05379595","publication_url":"https://clinicaltrials.gov/study/NCT05379595","title":"A Phase 1b/2, Open-Label Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer","has_exemption":false,"start_date":"2022-07-29","completion_date":"2027-04-27","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06364917","publication_url":"https://clinicaltrials.gov/study/NCT06364917","title":"DISCERN: Dual Immune Strategy Versus Single Checkpoint Inhibition Efficacy Response in PDL-1 Negative Non-Small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2025-05-30","completion_date":"2027-04-27","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06987695","publication_url":"https://clinicaltrials.gov/study/NCT06987695","title":"A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants in Japan Who Have Obesity Disease (MARITIME 3-J)","has_exemption":false,"start_date":"2025-06-13","completion_date":"2027-04-27","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07023627","publication_url":"https://clinicaltrials.gov/study/NCT07023627","title":"A Phase 2, Single-Arm Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression (MAESTRA 1)","has_exemption":false,"start_date":"2025-11-12","completion_date":"2027-04-27","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03173937","publication_url":"https://clinicaltrials.gov/study/NCT03173937","title":"Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn, Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells, to Expedite Engraftment and Improve Transplant Outcome","has_exemption":false,"start_date":"2017-06-13","completion_date":"2027-04-28","has_results":false,"results_due":false,"sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","sponsor_slug":"national-heart-lung-and-blood-institute-nhlbi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04624230","publication_url":"https://clinicaltrials.gov/study/NCT04624230","title":"OPEN-LABEL INDUCTION AND MAINTENANCE STUDY OF ORAL CP-690,550 (TOFACITINIB) IN CHILDREN WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS","has_exemption":false,"start_date":"2021-08-12","completion_date":"2027-04-28","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05529069","publication_url":"https://clinicaltrials.gov/study/NCT05529069","title":"Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients","has_exemption":false,"start_date":"2023-01-25","completion_date":"2027-04-28","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05715229","publication_url":"https://clinicaltrials.gov/study/NCT05715229","title":"A Multicenter Phase II Randomized Trial Of Immunotherapy Versus Chemotherapy Guided By Circulating Tumor DNA-Based Molecular Response On Patients With Metastatic NSCLC","has_exemption":false,"start_date":"2023-09-29","completion_date":"2027-04-28","has_results":false,"results_due":false,"sponsor_name":"Hackensack Meridian Health","sponsor_slug":"hackensack-meridian-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06111586","publication_url":"https://clinicaltrials.gov/study/NCT06111586","title":"A 52-week Randomized, Double-blind, Placebo-controlled, Multi-center Phase 2b Study With a 52-week Blinded Extension and an Optional Open-label Extension - Assessing Safety and Efficacy of Frexalimab, a CD40L-antagonist Monoclonal Antibody, for Preservation of Pancreatic β-cell Function in Adults and Adolescents With Newly Diagnosed Type 1 Diabetes on Insulin Therapy","has_exemption":false,"start_date":"2023-12-11","completion_date":"2027-04-28","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06238622","publication_url":"https://clinicaltrials.gov/study/NCT06238622","title":"An Open-label Extension Trial of the Long-term Safety and Efficacy of BI 1015550 Taken Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF) (FIBRONEER™-ON)","has_exemption":false,"start_date":"2024-05-06","completion_date":"2027-04-28","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06854614","publication_url":"https://clinicaltrials.gov/study/NCT06854614","title":"Sequential or CombinaTion Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)","has_exemption":false,"start_date":"2025-03-01","completion_date":"2027-04-28","has_results":false,"results_due":false,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06952556","publication_url":"https://clinicaltrials.gov/study/NCT06952556","title":"A Randomized, Single-blind, Single-center Study Measuring the Effects of Adductor Canal Block Combined With IPACK Infiltration Compared to Adductor Canal Block Alone on Post-operative Pain and Opioid Consumption in Patients Undergoing HTO/DFO/TTO","has_exemption":false,"start_date":"2025-04-28","completion_date":"2027-04-28","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07036523","publication_url":"https://clinicaltrials.gov/study/NCT07036523","title":"A Double-blind, Randomised, Placebo-controlled, Parallel Group, Phase IIa Trial to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of BI 765423 Administered Intravenously With or Without Standard of Care in Patients With Idiopathic Pulmonary Fibrosis","has_exemption":false,"start_date":"2025-11-13","completion_date":"2027-04-28","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03401788","publication_url":"https://clinicaltrials.gov/study/NCT03401788","title":"An Open-Label Phase 2 Study to Evaluate PT2977 for the Treatment of Von Hippel Lindau Disease-Associated Renal Cell Carcinoma","has_exemption":false,"start_date":"2018-05-02","completion_date":"2027-04-29","has_results":false,"results_due":false,"sponsor_name":"Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","sponsor_slug":"peloton-therapeutics-inc-a-subsidiary-of-merck-co-inc-rahway-new-jersey-usa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05983068","publication_url":"https://clinicaltrials.gov/study/NCT05983068","title":"A Two-year, Phase 4, Open-label, Single-arm Treatment Study to Evaluate the Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants (≥6 to <15 Years of Age) With Moderate-to-severe Atopic Dermatitis","has_exemption":false,"start_date":"2024-02-22","completion_date":"2027-04-29","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06812988","publication_url":"https://clinicaltrials.gov/study/NCT06812988","title":"A 52-week Randomized, Double-blind, Placebo-controlled, Multi-center Phase 2a Study Assessing Safety and Efficacy of Brivekimig, a Dual Anti-TNF-α and Anti-OX40L NANOBODY® Molecule, for Preservation of Pancreatic β-cell Function in Adults and Adolescents With Recently Diagnosed Type 1 Diabetes","has_exemption":false,"start_date":"2025-02-28","completion_date":"2027-04-29","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06918132","publication_url":"https://clinicaltrials.gov/study/NCT06918132","title":"Phase II Single Arm Study of Neoadjuvant Dual Checkpoint Blockade With Programmed Death-ligand 1 (PD1) and Lymphocyte Activation Gene 3 (LAG-3) Inhibition in Resectable Non-Small Cell Lung Cancer (N-PLANC)","has_exemption":false,"start_date":"2025-04-29","completion_date":"2027-04-29","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01512589","publication_url":"https://clinicaltrials.gov/study/NCT01512589","title":"Phase IIB Randomized Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for the Treatment of Esophageal Cancer","has_exemption":false,"start_date":"2012-04-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02227251","publication_url":"https://clinicaltrials.gov/study/NCT02227251","title":"A Phase 2b Open-label Study of Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)","has_exemption":false,"start_date":"2014-11-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Karyopharm Therapeutics Inc","sponsor_slug":"karyopharm-therapeutics-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02181257","publication_url":"https://clinicaltrials.gov/study/NCT02181257","title":"Extracorporeal Photopheresis for the Management of Progressive Bronchiolitis Obliterans Syndrome in Medicare-Eligible Recipients of Lung Allografts","has_exemption":false,"start_date":"2015-01-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02420860","publication_url":"https://clinicaltrials.gov/study/NCT02420860","title":"Phase II Study of the Combination of Elotuzumab With Lenalidomide as Maintenance Therapy Post Autologous Stem Cell Transplant in Patients With Multiple Myeloma","has_exemption":false,"start_date":"2015-04-14","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02429570","publication_url":"https://clinicaltrials.gov/study/NCT02429570","title":"Pilot Study of Meclofenamate in Subjects With Recurrent or Progressive Brain Metastasis From Solid Tumor Primary","has_exemption":false,"start_date":"2015-04-22","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02343042","publication_url":"https://clinicaltrials.gov/study/NCT02343042","title":"A Phase 1b/2 Study of Selinexor (KPT-330) in Combination With Backbone Treatments for Relapsed/Refractory Multiple Myeloma and Newly Diagnosed Multiple Myeloma","has_exemption":false,"start_date":"2015-10-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Karyopharm Therapeutics Inc","sponsor_slug":"karyopharm-therapeutics-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02960555","publication_url":"https://clinicaltrials.gov/study/NCT02960555","title":"Phase II Trial of Isatuximab (SAR650984) With or Without Lenalidomide in Patients With High Risk Smoldering Multiple Myeloma (ISAMAR)","has_exemption":false,"start_date":"2017-02-08","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03090633","publication_url":"https://clinicaltrials.gov/study/NCT03090633","title":"Study of Fetoscopic Repair of Myelomeningocele in Fetuses With Isolated Spina Bifida","has_exemption":false,"start_date":"2017-05-11","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03449108","publication_url":"https://clinicaltrials.gov/study/NCT03449108","title":"Clinical Study to Assess Efficacy and Safety of LN-145/LN-145-S1 (Autologous Centrally Manufactured Tumor Infiltrating Lymphocytes) Across Multiple Tumor Types","has_exemption":false,"start_date":"2018-04-27","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03463460","publication_url":"https://clinicaltrials.gov/study/NCT03463460","title":"A Multicenter, Phase II Trial of Pembrolizumab and Sunitinib in Refractory Advanced Thymic Carcinoma","has_exemption":false,"start_date":"2018-06-19","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Dwight Owen","sponsor_slug":"dwight-owen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03298334","publication_url":"https://clinicaltrials.gov/study/NCT03298334","title":"Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates: a Randomized Controlled Trial","has_exemption":false,"start_date":"2018-07-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03540758","publication_url":"https://clinicaltrials.gov/study/NCT03540758","title":"Regulation of Endogenous Glucose Production by Central KATP Channels","has_exemption":false,"start_date":"2018-08-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Albert Einstein College of Medicine","sponsor_slug":"albert-einstein-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03506308","publication_url":"https://clinicaltrials.gov/study/NCT03506308","title":"A Prospective, Global, Multicenter, Single Arm Post-Approval Study Investigating the Clinical Use and Safety of the Lutonix® Drug Coated Balloon PTA Catheter for the Treatment of Dysfunctional AV Fistulae","has_exemption":false,"start_date":"2018-08-07","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"C. R. Bard","sponsor_slug":"c-r-bard","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03586609","publication_url":"https://clinicaltrials.gov/study/NCT03586609","title":"Phase II Study of Venetoclax Added to Cladribine Plus Low Dose Cytarabine (LDAC) Induction Followed by Consolidation With Cladribine Plus LDAC Alternating With 5-Azacitidine With Venetoclax in Patients With Untreated AML","has_exemption":false,"start_date":"2018-10-25","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03964532","publication_url":"https://clinicaltrials.gov/study/NCT03964532","title":"TALAVE: A Pilot Trial of Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer","has_exemption":false,"start_date":"2019-04-17","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Georgetown University","sponsor_slug":"georgetown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04145622","publication_url":"https://clinicaltrials.gov/study/NCT04145622","title":"Phase I/II, Two-Part, Multicenter First-in-Human Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Subjects With Advanced Solid Malignant Tumors (IDeate-PanTumor01)","has_exemption":false,"start_date":"2019-11-03","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03899987","publication_url":"https://clinicaltrials.gov/study/NCT03899987","title":"Randomized Phase 2 Study: Neoadjuvant Conditioning of Prostate Cancer Tumor Microenvironment Using a Novel Chemokine-Modulating Regimen","has_exemption":false,"start_date":"2019-11-29","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04176198","publication_url":"https://clinicaltrials.gov/study/NCT04176198","title":"A Phase 1/2, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Oral Nuvisertib (TP-3654) in Patients With Intermediate or High-Risk Primary or Secondary Myelofibrosis","has_exemption":false,"start_date":"2019-12-16","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Sumitomo Pharma America, Inc.","sponsor_slug":"sumitomo-pharma-america-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03907046","publication_url":"https://clinicaltrials.gov/study/NCT03907046","title":"Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and Recovery","has_exemption":false,"start_date":"2020-01-28","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05986292","publication_url":"https://clinicaltrials.gov/study/NCT05986292","title":"A Master Protocol for Randomized, Placebo-Controlled, Phase 2 Clinical Trials of Multiple Interventions for the Treatment of Chronic Pain","has_exemption":false,"start_date":"2020-01-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04057898","publication_url":"https://clinicaltrials.gov/study/NCT04057898","title":"A Phase 2b/3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 12 Month Clinical Trial to Evaluate the Efficacy and Safety of MN-166 (Ibudilast) Followed by Open-Label Extension Phase in Subjects With Amyotrophic Lateral Sclerosis","has_exemption":false,"start_date":"2020-05-28","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"MediciNova","sponsor_slug":"medicinova","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04280718","publication_url":"https://clinicaltrials.gov/study/NCT04280718","title":"Open-label Extension of the ARGX-113-1802 Trial to Investigate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","has_exemption":false,"start_date":"2020-09-18","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04583644","publication_url":"https://clinicaltrials.gov/study/NCT04583644","title":"Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH)","has_exemption":false,"start_date":"2020-10-02","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Hanmin Lee","sponsor_slug":"hanmin-lee","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04071236","publication_url":"https://clinicaltrials.gov/study/NCT04071236","title":"A Phase I and Randomized Phase II Trial of Radium-223 Dichloride, M3814, &Amp; Avelumab in Advanced Metastatic Castrate-Resistant Prostate Cancer (mCRPC)","has_exemption":false,"start_date":"2020-10-14","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04402788","publication_url":"https://clinicaltrials.gov/study/NCT04402788","title":"RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial","has_exemption":false,"start_date":"2021-01-07","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03608631","publication_url":"https://clinicaltrials.gov/study/NCT03608631","title":"Phase I Study of Mesenchymal Stromal Cells-Derived Exosomes With KrasG12D siRNA for Metastatic Pancreas Cancer Patients Harboring KrasG12D Mutation","has_exemption":false,"start_date":"2021-01-27","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04701307","publication_url":"https://clinicaltrials.gov/study/NCT04701307","title":"Niraparib (PARP Inhibitor) Plus Dostarlimab (Anti-PD1) for Small Cell Lung Cancer (SCLC) and Other High-Grade Neuroendocrine Carcinomas (NEC)","has_exemption":false,"start_date":"2021-02-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04370301","publication_url":"https://clinicaltrials.gov/study/NCT04370301","title":"Pilot Study of JAK Inhibitor Therapy Followed by Reduced Intensity Haploidentical Transplantation for Patients With Myelofibrosis","has_exemption":true,"start_date":"2021-02-09","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04450173","publication_url":"https://clinicaltrials.gov/study/NCT04450173","title":"A Phase II Trial of the Combination of Obinutuzumab, Ibrutinib, and Venetoclax in Patients With Previously Untreated Follicular Lymphoma","has_exemption":false,"start_date":"2021-02-24","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03892980","publication_url":"https://clinicaltrials.gov/study/NCT03892980","title":"A Prospective, Multicenter Investigation of the da Vinci® Surgical Systems in Nipple Sparing Mastectomy (NSM) Procedures","has_exemption":false,"start_date":"2021-03-26","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Intuitive Surgical","sponsor_slug":"intuitive-surgical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05056844","publication_url":"https://clinicaltrials.gov/study/NCT05056844","title":"Contrast Enhanced Spectral Mammography (CESM) for the Evaluation of Pathologic Nipple Discharge: A Pilot Study","has_exemption":false,"start_date":"2021-04-15","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04872543","publication_url":"https://clinicaltrials.gov/study/NCT04872543","title":"A Phase II Study of ASTX727 in Patients With PRC2 Loss Malignant Peripheral Nerve Sheath Tumor (MPNST)","has_exemption":false,"start_date":"2021-04-29","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04476901","publication_url":"https://clinicaltrials.gov/study/NCT04476901","title":"A Phase IIB Randomized, Placebo-Controlled, Multicenter Study of the Comparative Efficacy and Safety of Administration of Allogeneic-MSC Versus Placebo in Patients With Non- Ischemic Dilated Cardiomyopathy","has_exemption":false,"start_date":"2021-05-07","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Joshua M Hare","sponsor_slug":"joshua-m-hare","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04956640","publication_url":"https://clinicaltrials.gov/study/NCT04956640","title":"A Phase 1/2 Study of LY3537982 in Patients With KRAS G12C-Mutant Advanced Solid Tumors","has_exemption":false,"start_date":"2021-07-19","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04041479","publication_url":"https://clinicaltrials.gov/study/NCT04041479","title":"Efficacy of Biomarker-guided rTMS for Treatment Resistant Depression","has_exemption":false,"start_date":"2021-09-17","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05050136","publication_url":"https://clinicaltrials.gov/study/NCT05050136","title":"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Biliary Cholangitis","has_exemption":false,"start_date":"2021-09-22","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Mirum Pharmaceuticals, Inc.","sponsor_slug":"mirum-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04908423","publication_url":"https://clinicaltrials.gov/study/NCT04908423","title":"Upper Extremity Injection of Xeomin® and Changes in Gait Related Mobility in Adults After Stroke","has_exemption":false,"start_date":"2021-10-19","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04905069","publication_url":"https://clinicaltrials.gov/study/NCT04905069","title":"Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy","has_exemption":false,"start_date":"2021-12-21","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04441034","publication_url":"https://clinicaltrials.gov/study/NCT04441034","title":"Integrating Pragmatic Comparative Effectiveness Research Into a Tertiary Pain Management Center","has_exemption":false,"start_date":"2022-04-12","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05353569","publication_url":"https://clinicaltrials.gov/study/NCT05353569","title":"Otitis Media Diagnosis and Treatment: Coherent Optical Detection of Middle Ear Disease","has_exemption":false,"start_date":"2022-05-24","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05174052","publication_url":"https://clinicaltrials.gov/study/NCT05174052","title":"Dapagliflozin in Patients With Atrial Fibrillation","has_exemption":false,"start_date":"2022-06-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06850922","publication_url":"https://clinicaltrials.gov/study/NCT06850922","title":"A Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Patients With Diabetic Macular Edema","has_exemption":false,"start_date":"2022-06-22","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Genentech, Inc.","sponsor_slug":"genentech-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05410145","publication_url":"https://clinicaltrials.gov/study/NCT05410145","title":"A Phase 1/2, Open Label, Dose-escalation, and Dose-expansion Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation","has_exemption":false,"start_date":"2022-08-03","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"D3 Bio (Wuxi) Co., Ltd","sponsor_slug":"d3-bio-wuxi-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05285527","publication_url":"https://clinicaltrials.gov/study/NCT05285527","title":"MiSight 1 Day Safety Post-Approval Study","has_exemption":false,"start_date":"2022-08-15","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Coopervision, Inc.","sponsor_slug":"coopervision-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04971499","publication_url":"https://clinicaltrials.gov/study/NCT04971499","title":"A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma","has_exemption":false,"start_date":"2022-09-06","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"April Salama, M.D.","sponsor_slug":"april-salama-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05708885","publication_url":"https://clinicaltrials.gov/study/NCT05708885","title":"Characterization of the Striated Esophagus (St.Eso) Deglutitive Motor Function and Its Modulation by Pharyngeal Phase Swallow Biomechanics","has_exemption":false,"start_date":"2022-09-13","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05190978","publication_url":"https://clinicaltrials.gov/study/NCT05190978","title":"Randomized Feasibility Trial for Mesh in Pre-Pectoral Reconstruction","has_exemption":false,"start_date":"2022-10-20","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05596318","publication_url":"https://clinicaltrials.gov/study/NCT05596318","title":"Efficacy of Digital Cognitive Behavior Therapy for Insomnia for the Prevention of Perinatal Depression","has_exemption":false,"start_date":"2022-11-02","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05279742","publication_url":"https://clinicaltrials.gov/study/NCT05279742","title":"Enhancing the Natriuretic Peptide System in HFpEF: A Randomized Double-Blind Placebo-Controlled Triple Crossover Study","has_exemption":false,"start_date":"2022-11-04","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Horng Chen","sponsor_slug":"horng-chen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05185505","publication_url":"https://clinicaltrials.gov/study/NCT05185505","title":"Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria: A Feasibility Study","has_exemption":false,"start_date":"2023-01-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05667142","publication_url":"https://clinicaltrials.gov/study/NCT05667142","title":"A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures","has_exemption":false,"start_date":"2023-02-14","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Xenon Pharmaceuticals Inc.","sponsor_slug":"xenon-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05445778","publication_url":"https://clinicaltrials.gov/study/NCT05445778","title":"Randomized, Multicenter, Open-label, Phase 3 Study of Mirvetuximab Soravtansine in Combination With Bevacizumab Versus Bevacizumab Alone as Maintenance Therapy for Patients With FRα-high Recurrent Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers Who Have Not Progressed After Second Line Platinum-based Chemotherapy Plus Bevacizumab","has_exemption":false,"start_date":"2023-03-15","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06118268","publication_url":"https://clinicaltrials.gov/study/NCT06118268","title":"iTBS to Enhance Social Cognition in People With Psychosis","has_exemption":false,"start_date":"2023-04-18","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05613608","publication_url":"https://clinicaltrials.gov/study/NCT05613608","title":"Alcohol Use Disorder and Cannabis: Testing Novel Harm Reduction Strategies","has_exemption":false,"start_date":"2023-04-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05646485","publication_url":"https://clinicaltrials.gov/study/NCT05646485","title":"Optimal Screening Strategy for Bladder Cancer in at Risk Patients","has_exemption":false,"start_date":"2023-05-05","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05683691","publication_url":"https://clinicaltrials.gov/study/NCT05683691","title":"Prospective, Multicenter, Single-Arm Study of VanquishTM Water Vapor Ablation for PrOstate CanceR","has_exemption":false,"start_date":"2023-05-16","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Francis Medical Inc.","sponsor_slug":"francis-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05703256","publication_url":"https://clinicaltrials.gov/study/NCT05703256","title":"Confirmatory Efficacy Randomized Clinical Trial of Amygdala Neurofeedback for Major Depressive Disorder","has_exemption":false,"start_date":"2023-06-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Kymberly Young","sponsor_slug":"kymberly-young","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05531656","publication_url":"https://clinicaltrials.gov/study/NCT05531656","title":"Synaptic Therapy Alzheimer's Research Trial (START): A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease Over 18 Months.","has_exemption":false,"start_date":"2023-06-28","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Cognition Therapeutics","sponsor_slug":"cognition-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05907954","publication_url":"https://clinicaltrials.gov/study/NCT05907954","title":"(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma","has_exemption":false,"start_date":"2023-07-03","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"IDEAYA Biosciences","sponsor_slug":"ideaya-biosciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05933148","publication_url":"https://clinicaltrials.gov/study/NCT05933148","title":"Network-based Real-time Neurofeedback Using Ultra-high Field MRI to Reduce Rumination Levels in Depression","has_exemption":false,"start_date":"2023-07-12","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05511987","publication_url":"https://clinicaltrials.gov/study/NCT05511987","title":"A Randomized Controlled Trial of a Digital Chest Tube Drainage System (Thopaz+) Versus Analog in Pediatric Patients","has_exemption":false,"start_date":"2023-08-15","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05559879","publication_url":"https://clinicaltrials.gov/study/NCT05559879","title":"A Phase Ib/II Single Arm Study of Cabozantinib Plus Dostarlimab in Women With Recurrent Gynecologic Carcinosarcoma","has_exemption":false,"start_date":"2023-08-20","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05975580","publication_url":"https://clinicaltrials.gov/study/NCT05975580","title":"Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery","has_exemption":false,"start_date":"2023-08-29","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Irvine","sponsor_slug":"university-of-california-irvine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05696626","publication_url":"https://clinicaltrials.gov/study/NCT05696626","title":"An Open Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of the Combination of Lasofoxifene and Abemaciclib to the Combination of Fulvestrant and Abemaciclib for the Treatment of Pre- and Postmenopausal Women and Men With Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation","has_exemption":false,"start_date":"2023-10-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"LeonaBio","sponsor_slug":"leonabio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05291676","publication_url":"https://clinicaltrials.gov/study/NCT05291676","title":"Systems Investigation of Vaccine Responses in Aging and Frailty","has_exemption":false,"start_date":"2023-11-06","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06494891","publication_url":"https://clinicaltrials.gov/study/NCT06494891","title":"Translational Underpinnings of Motivation for Alcohol in Humans","has_exemption":false,"start_date":"2024-01-16","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06244082","publication_url":"https://clinicaltrials.gov/study/NCT06244082","title":"A Phase 2 Open-label Study to Evaluate the Pharmacodynamics and Long-Term Safety and Tolerability of AOC 1044 Administered Intravenously to DMD Participants With Mutations Amenable to Exon 44 Skipping","has_exemption":false,"start_date":"2024-01-22","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Avidity Biosciences, Inc.","sponsor_slug":"avidity-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06189638","publication_url":"https://clinicaltrials.gov/study/NCT06189638","title":"A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Antimicrobial Peptide PL-5 Topical Spray in Patients With Mild Infections of Diabetic Foot Ulcers","has_exemption":false,"start_date":"2024-01-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.","sponsor_slug":"jiangsu-protelight-pharmaceutical-biotechnology-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06095505","publication_url":"https://clinicaltrials.gov/study/NCT06095505","title":"A Phase 2 Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer","has_exemption":false,"start_date":"2024-02-08","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Puma Biotechnology, Inc.","sponsor_slug":"puma-biotechnology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06458062","publication_url":"https://clinicaltrials.gov/study/NCT06458062","title":"Development and Validation of an Artificial-Intelligence-enabled Portable Colposcopy Device for Optimizing Triage Alternatives for HPV-based Cervical Cancer Screening","has_exemption":false,"start_date":"2024-02-15","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06280352","publication_url":"https://clinicaltrials.gov/study/NCT06280352","title":"Prospective Randomized Controlled Trial of Functionally Aligned Robotically Assisted Total Knee Arthroplasty vs Patient Specific Custom Made Total Knee Arthroplasty","has_exemption":false,"start_date":"2024-03-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Austrian Workers Compensation Board Styria","sponsor_slug":"austrian-workers-compensation-board-styria","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06387485","publication_url":"https://clinicaltrials.gov/study/NCT06387485","title":"A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning","has_exemption":false,"start_date":"2024-03-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Ricoh USA, Inc.","sponsor_slug":"ricoh-usa-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05932615","publication_url":"https://clinicaltrials.gov/study/NCT05932615","title":"Evaluation of the Navitor Transcatheter Heart Valve in Low and Intermediate Risk Patients Who Have Severe, Symptomatic, Aortic Stenosis Requiring Aortic Valve Replacement","has_exemption":false,"start_date":"2024-03-15","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Abbott Medical Devices","sponsor_slug":"abbott-medical-devices","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06257056","publication_url":"https://clinicaltrials.gov/study/NCT06257056","title":"Closed Loop Neuromodulation for Treatment-refractory Schizophrenia: A Pilot Study","has_exemption":false,"start_date":"2024-04-03","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Bradley Lega","sponsor_slug":"bradley-lega","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06152653","publication_url":"https://clinicaltrials.gov/study/NCT06152653","title":"The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC","has_exemption":false,"start_date":"2024-04-09","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05830942","publication_url":"https://clinicaltrials.gov/study/NCT05830942","title":"Cognitively Engaging Walking Exercise and Neuromodulation to Enhance Brain Function in Older Adults","has_exemption":false,"start_date":"2024-04-15","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05219175","publication_url":"https://clinicaltrials.gov/study/NCT05219175","title":"MDMA-Assisted Therapy 6 to 12 Months After Childbirth for People With Co-occurring Opioid Use and Post Traumatic Stress Disorders","has_exemption":false,"start_date":"2024-04-16","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of New Mexico","sponsor_slug":"university-of-new-mexico","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06377566","publication_url":"https://clinicaltrials.gov/study/NCT06377566","title":"BV-AVD in Patients With Newly-Diagnosed, Early Stage, Bulky Hodgkin Lymphoma Using a PET-adapted and MTV-guided Approach","has_exemption":false,"start_date":"2024-04-17","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05988918","publication_url":"https://clinicaltrials.gov/study/NCT05988918","title":"A Phase II Multicenter Trial of ESK981 in Patients With Select Solid Tumors","has_exemption":false,"start_date":"2024-04-19","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Michigan Rogel Cancer Center","sponsor_slug":"university-of-michigan-rogel-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06394804","publication_url":"https://clinicaltrials.gov/study/NCT06394804","title":"Combination Targeted and Hormonal treAtMEnt of Low-gradE Serous Ovarian Cancer in the upfroNt Setting","has_exemption":false,"start_date":"2024-04-29","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06048484","publication_url":"https://clinicaltrials.gov/study/NCT06048484","title":"A Phase 2, Open-Label, Multicenter, Randomized Study Evaluating Neoadjuvant Therapy Targeting the Adenosine Immunosuppressive Pathway in Combination With Immune Checkpoint Blockade and Radiation Therapy in Patients With Advanced PANCreatic Ductal Adenocarcinoma Who Are Candidates for Surgical Resection","has_exemption":false,"start_date":"2024-05-10","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Gulam Manji","sponsor_slug":"gulam-manji","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06372964","publication_url":"https://clinicaltrials.gov/study/NCT06372964","title":"A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Lumateperone for the Treatment of Major Depressive Episodes (MDEs) Associated With Bipolar I or Bipolar II Disorder (Bipolar Depression) in Pediatric Patients Aged 10 to 17 Years","has_exemption":false,"start_date":"2024-05-13","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Intra-Cellular Therapies, Inc.","sponsor_slug":"intra-cellular-therapies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05961709","publication_url":"https://clinicaltrials.gov/study/NCT05961709","title":"The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer","has_exemption":false,"start_date":"2024-05-20","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06203210","publication_url":"https://clinicaltrials.gov/study/NCT06203210","title":"A Phase 3, Multicenter, Randomized, Open-label Study of Ifinatamab Deruxtecan (I-DXd), a B7-H3 Antibody Drug Conjugate (ADC), Versus Treatment of Physician's Choice (TPC) in Subjects With Relapsed Small Cell Lung Cancer (SCLC) (IDeate-Lung02)","has_exemption":false,"start_date":"2024-05-21","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06278779","publication_url":"https://clinicaltrials.gov/study/NCT06278779","title":"Comparative Effectiveness Study of Two Forms of Ketamine for Treatment-Resistant Depression: a Randomised, Rater-blinded Trial","has_exemption":false,"start_date":"2024-06-03","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"The George Institute","sponsor_slug":"the-george-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06384664","publication_url":"https://clinicaltrials.gov/study/NCT06384664","title":"Cryoablation Effects on Acute and Chronic Pain After Thoracotomy and Thoracoscopy","has_exemption":false,"start_date":"2024-06-03","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06557265","publication_url":"https://clinicaltrials.gov/study/NCT06557265","title":"A Phase 1/2 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects With Autoimmune Disease","has_exemption":false,"start_date":"2024-06-13","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Nkarta, Inc.","sponsor_slug":"nkarta-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06399757","publication_url":"https://clinicaltrials.gov/study/NCT06399757","title":"A Phase 1/2 Study to Assess the Safety and Antitumor Activity of APL-5125 in Adults With Selected Advanced Solid Tumors","has_exemption":false,"start_date":"2024-06-18","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Apollo Therapeutics Ltd","sponsor_slug":"apollo-therapeutics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06172127","publication_url":"https://clinicaltrials.gov/study/NCT06172127","title":"A Multicenter, Open-Label, Single-Arm, Phase II Trial Exploring the Maintenance of Trastuzumab and Pertuzumab Following Trastuzumab Deruxtecan as Induction Treatment for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer","has_exemption":false,"start_date":"2024-07-22","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"MedSIR","sponsor_slug":"medsir","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06517758","publication_url":"https://clinicaltrials.gov/study/NCT06517758","title":"A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Iptacopan in Patients With Generalized Myasthenia Gravis, Followed by an Open-label Extension Phase","has_exemption":false,"start_date":"2024-07-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06162572","publication_url":"https://clinicaltrials.gov/study/NCT06162572","title":"A Phase 1b/2, Multicenter, Open-label Platform Study of Select Immunotherapy Combinations in Adult Participants With Previously Untreated Advanced Non-small Cell Lung Cancer (NSCLC) With High PD-L1 Expression","has_exemption":false,"start_date":"2024-08-07","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Servier Bio-Innovation LLC","sponsor_slug":"servier-bio-innovation-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06409390","publication_url":"https://clinicaltrials.gov/study/NCT06409390","title":"A Pilot Study of Sequential (\"First Strike, Second Strike\") Therapies, Modeled on Evolutionary Dynamics of Anthropocene Extinctions, for Hormone Positive Metastatic Breast Cancer","has_exemption":false,"start_date":"2024-08-14","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06423430","publication_url":"https://clinicaltrials.gov/study/NCT06423430","title":"Treatment ResistAnt Depression Subcallosal CingulatE Network DBS","has_exemption":false,"start_date":"2024-09-11","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Abbott Medical Devices","sponsor_slug":"abbott-medical-devices","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06384976","publication_url":"https://clinicaltrials.gov/study/NCT06384976","title":"KYSA-7: A Phase 2, Open-Label, Randomized, Multicenter Study of KYV-101, an Autologous Fully Human Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis","has_exemption":false,"start_date":"2024-09-20","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Kyverna Therapeutics","sponsor_slug":"kyverna-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06506955","publication_url":"https://clinicaltrials.gov/study/NCT06506955","title":"An Open-label, Rollover Study of Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib Study","has_exemption":false,"start_date":"2024-10-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Taiho Oncology, Inc.","sponsor_slug":"taiho-oncology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06598462","publication_url":"https://clinicaltrials.gov/study/NCT06598462","title":"A Phase 2, Randomized, Double-Blind, Multicenter, Placebo Controlled Study With an Extension to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis (ALAMERE)","has_exemption":false,"start_date":"2024-10-16","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Uniquity One (UNI)","sponsor_slug":"uniquity-one-uni","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06656364","publication_url":"https://clinicaltrials.gov/study/NCT06656364","title":"Esprit BTK Post-Approval Study (Esprit BTK PAS)","has_exemption":false,"start_date":"2024-10-21","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Abbott Medical Devices","sponsor_slug":"abbott-medical-devices","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06523530","publication_url":"https://clinicaltrials.gov/study/NCT06523530","title":"Effect of the Pharmacological Cessation of Menstruation With a GnRH Analog on Hepatic Steatosis in Women With Endometriosis","has_exemption":false,"start_date":"2024-11-26","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Aristotle University Of Thessaloniki","sponsor_slug":"aristotle-university-of-thessaloniki","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06384651","publication_url":"https://clinicaltrials.gov/study/NCT06384651","title":"Intraosseous vs. Intravenous Vancomycin Administration in Total Ankle Arthroplasty","has_exemption":false,"start_date":"2024-12-03","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06248216","publication_url":"https://clinicaltrials.gov/study/NCT06248216","title":"Implementation of an At-Home Multimodal Integrative Therapy Via Virtual Reality for Patients With Cancer-Treatment Associated Symptoms","has_exemption":false,"start_date":"2024-12-04","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06494904","publication_url":"https://clinicaltrials.gov/study/NCT06494904","title":"ED-Initiated Standard Versus High Dose Buprenorphine Induction","has_exemption":false,"start_date":"2024-12-06","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06510491","publication_url":"https://clinicaltrials.gov/study/NCT06510491","title":"A Phase 2 Trial Investigating Epcoritamab in Patients With Previously Treated Waldenstrom Macroglobulinemia (WM)","has_exemption":false,"start_date":"2024-12-06","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Gottfried von Keudell, MD PhD","sponsor_slug":"gottfried-von-keudell-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06489028","publication_url":"https://clinicaltrials.gov/study/NCT06489028","title":"A Pivotal, Randomized, Placebo-controlled, Double-blind, Multicenter, International Phase III Clinical Trial to Investigate the Efficacy and Safety of Allo-APZ2-CVU on Wound Healing of Therapy-Resistant Non-Healing Chronic Venous Ulcers (CVU)","has_exemption":false,"start_date":"2024-12-26","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"RHEACELL GmbH & Co. KG","sponsor_slug":"rheacell-gmbh-co-kg","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06471504","publication_url":"https://clinicaltrials.gov/study/NCT06471504","title":"Use of Eye Tracking to Aid in Autism Risk Detection","has_exemption":false,"start_date":"2025-01-08","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07392723","publication_url":"https://clinicaltrials.gov/study/NCT07392723","title":"Alpha Linolenic Acid-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults With Mild Cognitive Impairment: Targeting Cerebrovascular and Blood-brain Barrier Health","has_exemption":false,"start_date":"2025-01-12","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Michal Schnaider Beeri, Ph.D.","sponsor_slug":"michal-schnaider-beeri-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06696313","publication_url":"https://clinicaltrials.gov/study/NCT06696313","title":"Radiographic Migration Analysis of the Insignia Hip Stem","has_exemption":false,"start_date":"2025-01-15","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Canadian Radiostereometric Analysis Network","sponsor_slug":"canadian-radiostereometric-analysis-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07032285","publication_url":"https://clinicaltrials.gov/study/NCT07032285","title":"Multicenter, Open-Label Phase II Trial of Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas","has_exemption":false,"start_date":"2025-01-15","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas","sponsor_slug":"asociacion-europea-y-latinoamericana-selnet-para-la-investigacion-en-sarcomas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06699797","publication_url":"https://clinicaltrials.gov/study/NCT06699797","title":"Pivotal Clinical Trial Evaluating the Safety and Efficacy of the Fully Implanted Acclaim Cochlear Implant","has_exemption":false,"start_date":"2025-02-06","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Envoy Medical Corporation","sponsor_slug":"envoy-medical-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06289491","publication_url":"https://clinicaltrials.gov/study/NCT06289491","title":"Randomized Trial of Hydrus Microstent Versus Goniotomy","has_exemption":false,"start_date":"2025-02-14","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts Eye and Ear Infirmary","sponsor_slug":"massachusetts-eye-and-ear-infirmary","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06980805","publication_url":"https://clinicaltrials.gov/study/NCT06980805","title":"A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Active Subacute Cutaneous Lupus Erythematosus (SCLE) and/or Chronic Cutaneous Lupus Erythematosus (CCLE) With or Without Systemic Manifestations","has_exemption":false,"start_date":"2025-02-19","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Immunovant Sciences GmbH","sponsor_slug":"immunovant-sciences-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06736704","publication_url":"https://clinicaltrials.gov/study/NCT06736704","title":"A Phase 1/2, Open-Label Dose Escalation and Expansion Study of SNV4818 as Monotherapy or in Combination With Other Anticancer Agents in Participants With Advanced Solid Tumors","has_exemption":false,"start_date":"2025-02-20","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Pikavation Therapeutics, Inc.","sponsor_slug":"pikavation-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06281925","publication_url":"https://clinicaltrials.gov/study/NCT06281925","title":"A Phase II Randomized Interventional Pilot Study for Colon Cancer Patients Receiving Oxaliplatin: Benefits of Cryotherapy in Prevention of Peripheral Neuropathy","has_exemption":false,"start_date":"2025-03-13","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06453785","publication_url":"https://clinicaltrials.gov/study/NCT06453785","title":"Comparing pOrtable MRI and TRUS-Fusion Prostate Biopsy to Assess aCcuracy of Prostate Cancer Detection","has_exemption":false,"start_date":"2025-03-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Imperial College London","sponsor_slug":"imperial-college-london","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06925724","publication_url":"https://clinicaltrials.gov/study/NCT06925724","title":"A Phase 2 Study of Ivonescimab (Bispecific Antibody Against PD1 and VEGF) For the Treatment of Endometrial (EC) and Cervical (CC) Cancers","has_exemption":false,"start_date":"2025-04-04","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06866691","publication_url":"https://clinicaltrials.gov/study/NCT06866691","title":"Seizure Prevention in Traumatic Brain Injury: A Comparative Effectiveness Study of Levetiracetam and Lacosamide","has_exemption":false,"start_date":"2025-04-18","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06957327","publication_url":"https://clinicaltrials.gov/study/NCT06957327","title":"A Phase 1b/2 Study of ERAS-601 SHP2 Inhibitor as a Monotherapy in Patients With Advanced and Progressing Chordoma","has_exemption":false,"start_date":"2025-04-25","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06470035","publication_url":"https://clinicaltrials.gov/study/NCT06470035","title":"A Randomized, Double Blind Sham Controlled Clinical Trial to Evaluate the Efficacy of Electrical Vestibular Nerve Stimulation (VeNS), Compared to a Sham Control for Treatment of Major Depressive Disorder (MDD) - Modius Mood Study","has_exemption":false,"start_date":"2025-04-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Neurovalens Ltd.","sponsor_slug":"neurovalens-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06742801","publication_url":"https://clinicaltrials.gov/study/NCT06742801","title":"PELE IDE Clinical Study, Peripheral Onyx™ Liquid Embolic Safety and Effectiveness of The Onyx™ LES for Embolization of Arterial Hemorrhage in the Peripheral Vasculature","has_exemption":false,"start_date":"2025-05-09","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Medtronic Endovascular","sponsor_slug":"medtronic-endovascular","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07020026","publication_url":"https://clinicaltrials.gov/study/NCT07020026","title":"Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease Using [18F]PI-2620: A High-resolution PET Imaging Study Using NeuroEXPLORER (NX PI-2160 in PD)","has_exemption":false,"start_date":"2025-05-12","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Michael J. Fox Foundation for Parkinson's Research","sponsor_slug":"michael-j-fox-foundation-for-parkinsons-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06834165","publication_url":"https://clinicaltrials.gov/study/NCT06834165","title":"A Phase IV Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy","has_exemption":false,"start_date":"2025-05-20","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"ARS Pharmaceuticals, Inc.","sponsor_slug":"ars-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06999278","publication_url":"https://clinicaltrials.gov/study/NCT06999278","title":"LIGHT - Levothyroxine for Isolated Gestational HypoThyroidism in Women With Recurrent Pregnancy Loss: a Multicenter Randomized, Double-blind, Placebo-controlled Trial - a Study Protocol","has_exemption":false,"start_date":"2025-06-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Women's Hospital School Of Medicine Zhejiang University","sponsor_slug":"womens-hospital-school-of-medicine-zhejiang-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06735534","publication_url":"https://clinicaltrials.gov/study/NCT06735534","title":"The ReMATCH Study is a Prospective, Single Arm, Open Label, Multi-center, Study Utilizing the FARAPULSE PFA System, Including the FARAWAVE and FARAPOINT PFA Catheters","has_exemption":false,"start_date":"2025-06-03","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06895473","publication_url":"https://clinicaltrials.gov/study/NCT06895473","title":"A Phase 2 Study of Prophylactic IT Chemotherapy to Prevent High-Grade Chimeric Antigen Receptor (CAR) T-Cell-Associated Neurotoxicity Syndrome","has_exemption":false,"start_date":"2025-06-04","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"OHSU Knight Cancer Institute","sponsor_slug":"ohsu-knight-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06968494","publication_url":"https://clinicaltrials.gov/study/NCT06968494","title":"Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction Following Radical Prostatectomy","has_exemption":false,"start_date":"2025-06-05","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Comphya Inc.","sponsor_slug":"comphya-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06999304","publication_url":"https://clinicaltrials.gov/study/NCT06999304","title":"Personalized Accelerated Theta Burst Transcardial Magnetic Stimulation in Mild Traumatic Brain Injury","has_exemption":false,"start_date":"2025-06-18","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"HealthPartners Institute","sponsor_slug":"healthpartners-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07033026","publication_url":"https://clinicaltrials.gov/study/NCT07033026","title":"A Phase 2, Multicenter, Randomized, Double Blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of NGM120 in Participants With Colorectal Cancer Who Have Cancer Cachexia","has_exemption":false,"start_date":"2025-06-25","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"NGM Biopharmaceuticals, Inc","sponsor_slug":"ngm-biopharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06740890","publication_url":"https://clinicaltrials.gov/study/NCT06740890","title":"A Proof of Concept Study of Time Limited Exercise Plus Olanzapine-samidorphan for the Prevention of Early Weight Gain","has_exemption":false,"start_date":"2025-06-26","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"New York State Psychiatric Institute","sponsor_slug":"new-york-state-psychiatric-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07113522","publication_url":"https://clinicaltrials.gov/study/NCT07113522","title":"A Phase 2, Multi-Center, Platform Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics With Multiple Therapies in Participants With Active Crohn's Disease or Active Ulcerative Colitis (ASCEND-IBD)","has_exemption":false,"start_date":"2025-06-26","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Mirador Therapeutics, Inc.","sponsor_slug":"mirador-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06665100","publication_url":"https://clinicaltrials.gov/study/NCT06665100","title":"Efficacy and Safety of PUL-042 Inhalation Solution in Reducing Lower Respiratory Tract Complications in Patients With Hematologic Malignancies and Recipients of Hematopoietic Stem Cell Transplantation (HSCT) With Documented Viral Infections With PIV, hMPV or RSV","has_exemption":false,"start_date":"2025-06-27","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Pulmotect, Inc.","sponsor_slug":"pulmotect-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07025720","publication_url":"https://clinicaltrials.gov/study/NCT07025720","title":"Accelerated Intermittent Theta Burst Stimulation for Adolescent and Young Adult Depression With Elevated Suicide Risk","has_exemption":false,"start_date":"2025-07-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07095660","publication_url":"https://clinicaltrials.gov/study/NCT07095660","title":"RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-IRL)","has_exemption":false,"start_date":"2025-07-02","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Intervene, Inc.","sponsor_slug":"intervene-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217392","publication_url":"https://clinicaltrials.gov/study/NCT07217392","title":"Left Bundle Branch Area Pacing (LBBAP) PMCF Study","has_exemption":false,"start_date":"2025-07-24","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Abbott Medical Devices","sponsor_slug":"abbott-medical-devices","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07079761","publication_url":"https://clinicaltrials.gov/study/NCT07079761","title":"Facilitation of Extinction Retention and Reconsolidation Blockade by IV Allopregnanolone in PTSD.","has_exemption":false,"start_date":"2025-08-04","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06864403","publication_url":"https://clinicaltrials.gov/study/NCT06864403","title":"Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch","has_exemption":false,"start_date":"2025-08-12","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06968143","publication_url":"https://clinicaltrials.gov/study/NCT06968143","title":"Evaluating the Impact of Remote Therapeutic Monitoring on Knee Arthroplasty Recovery","has_exemption":false,"start_date":"2025-09-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06999603","publication_url":"https://clinicaltrials.gov/study/NCT06999603","title":"A Phase 2, Two-part Study to Assess the Safety, Antiviral Biomarker Responses, and Efficacy of Inhaled SNG001 for the Treatment of Patients With a Confirmed Respiratory Virus Infection Undergoing Invasive Mechanical Ventilation","has_exemption":false,"start_date":"2025-09-02","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Synairgen Research Ltd.","sponsor_slug":"synairgen-research-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06915662","publication_url":"https://clinicaltrials.gov/study/NCT06915662","title":"Pain Outcomes After Digital Amputation Using Tulavi Allay™ Nerve Cap: A Prospective Trial for Safety and Efficacy","has_exemption":false,"start_date":"2025-09-20","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220460","publication_url":"https://clinicaltrials.gov/study/NCT07220460","title":"Multicenter, Open-label Study to Evaluate the Long-term Safety and Tolerability of ABBV-932 in Subjects With Depressive Episodes Associated With Bipolar I or II Disorder","has_exemption":false,"start_date":"2025-09-30","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07219771","publication_url":"https://clinicaltrials.gov/study/NCT07219771","title":"A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase 3 Study of Intra-Articular Administration of an Allogeneic Human Placental Tissue Particulate (PTP-001) for the Treatment of Knee Osteoarthritis","has_exemption":false,"start_date":"2025-10-14","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Doron Therapeutics Inc.","sponsor_slug":"doron-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220811","publication_url":"https://clinicaltrials.gov/study/NCT07220811","title":"Phase 2b Randomized, Double-Blind, Placebo-Controlled Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy","has_exemption":false,"start_date":"2025-10-22","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"RAPT Therapeutics, Inc.","sponsor_slug":"rapt-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06959121","publication_url":"https://clinicaltrials.gov/study/NCT06959121","title":"Pulse Biosciences' CellFX nsPFA Cardiac Surgery Clamp System for the Treatment of Atrial Fibrillation During Concomitant Cardiac Surgery","has_exemption":false,"start_date":"2025-10-23","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Pulse Biosciences, Inc.","sponsor_slug":"pulse-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06804811","publication_url":"https://clinicaltrials.gov/study/NCT06804811","title":"A Phase 3, Randomized, Double-Blind, Efficacy, and Safety Study of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo","has_exemption":false,"start_date":"2025-11-13","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06658899","publication_url":"https://clinicaltrials.gov/study/NCT06658899","title":"A Phase 2, Double-Blind, Repeat-Dose, Placebo-Controlled Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CRD-4730 In Participants With Catecholaminergic Polymorphic Ventricular Tachycardia","has_exemption":false,"start_date":"2025-12-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Cardurion Pharmaceuticals, Inc.","sponsor_slug":"cardurion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07090135","publication_url":"https://clinicaltrials.gov/study/NCT07090135","title":"Enhance the Restorative Power of Sleep Through TES-TI Power Naps","has_exemption":false,"start_date":"2025-12-19","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07400952","publication_url":"https://clinicaltrials.gov/study/NCT07400952","title":"Multicenter, Randomized, Double-Masked, Placebo-Controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus","has_exemption":false,"start_date":"2025-12-23","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Glaukos Corporation","sponsor_slug":"glaukos-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221734","publication_url":"https://clinicaltrials.gov/study/NCT07221734","title":"Randomised, Multicentre, Multinational, Double-Blind Integrated Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 (Proposed Nivolumab Biosimilar) Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced (Unresectable or Metastatic) Melanoma (LEON Study)","has_exemption":false,"start_date":"2025-12-29","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"mAbxience Research S.L.","sponsor_slug":"mabxience-research-sl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07222969","publication_url":"https://clinicaltrials.gov/study/NCT07222969","title":"An Open-label, Dose-escalation and Dose-expansion Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic (PK) Characteristics, and Preliminary Efficacy of VIB305 in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2026-01-12","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Vibrant Sciences Limited","sponsor_slug":"vibrant-sciences-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07282743","publication_url":"https://clinicaltrials.gov/study/NCT07282743","title":"A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Tolerability of GL0034 Among Type II Diabetes Mellitus Subjects Who Are Obese or Overweight With Weight-related Comorbidities","has_exemption":false,"start_date":"2026-01-20","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Sun Pharmaceutical Industries Limited","sponsor_slug":"sun-pharmaceutical-industries-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07141342","publication_url":"https://clinicaltrials.gov/study/NCT07141342","title":"The Fast In-Bed Tracking (FIT) System Lifestyle Intervention","has_exemption":false,"start_date":"2026-02-16","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Jonathan Pearlman","sponsor_slug":"jonathan-pearlman","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07486713","publication_url":"https://clinicaltrials.gov/study/NCT07486713","title":"A Multi-Center, Open-Label, Drug-Drug Interaction Study to Evaluate the Effect of Olutasidenib on the Pharmacokinetics of CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP3A4, and OATP1B1 Substrates in Patients With IDH1 Mutation-Positive Malignancies Being Treated With Olutasidenib","has_exemption":false,"start_date":"2026-02-23","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Rigel Pharmaceuticals","sponsor_slug":"rigel-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07369076","publication_url":"https://clinicaltrials.gov/study/NCT07369076","title":"A Phase 1b/2 Study to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.","has_exemption":false,"start_date":"2026-02-28","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Nura Bio","sponsor_slug":"nura-bio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06875206","publication_url":"https://clinicaltrials.gov/study/NCT06875206","title":"Visual Restoration Using Focused Ultrasound Stimulation and Immersive Virtual Reality After Stroke","has_exemption":false,"start_date":"2026-03-01","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07523191","publication_url":"https://clinicaltrials.gov/study/NCT07523191","title":"Prospective Validation of a Reduced-Montage TMS-EEG Complexity Algorithm (Presence-IP1.0) to Differentiate Conscious and Unconscious States Across Wakefulness and Sleep","has_exemption":false,"start_date":"2026-03-18","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07078604","publication_url":"https://clinicaltrials.gov/study/NCT07078604","title":"A Phase II Trial of the Immunogenicity of a DNA Plasmid-Based Vaccine (STEMVAC) Encoding Th1 Selective Epitopes From Five Antigens Associated With Breast Cancer Stem Cells (MDM2, YB1, SOX2, CDH3, CD105) in Patients With Metastatic Triple-Negative Breast Cancer","has_exemption":false,"start_date":"2026-03-20","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07086534","publication_url":"https://clinicaltrials.gov/study/NCT07086534","title":"A Clinical Study of GeminiOne Transcatheter Edge-to-Edge Repair (TEER) System for the Treatment of Severe, Symptomatic Mitral Regurgitation (MR).","has_exemption":false,"start_date":"2026-03-26","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Sierra Valve LLC","sponsor_slug":"sierra-valve-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224958","publication_url":"https://clinicaltrials.gov/study/NCT07224958","title":"ROAM OA: Functional and Patient Reported Outcomes Wearing a Knee Brace for Unicompartmental OA","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07346066","publication_url":"https://clinicaltrials.gov/study/NCT07346066","title":"A Phase 3 Multi-Center Efficacy Study of Filricianine Injection in Patients Undergoing Robotic-Assisted Colorectal Surgery Using the da Vinci Surgical System With Firefly® Fluorescence Imaging","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Intuitive Surgical","sponsor_slug":"intuitive-surgical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07477171","publication_url":"https://clinicaltrials.gov/study/NCT07477171","title":"Comparison of Two Root Canal Filling Materials in Non-Surgical Endodontic Retreatment: A Randomized Controlled Clinical Trial","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Santiago de Compostela","sponsor_slug":"university-of-santiago-de-compostela","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07504198","publication_url":"https://clinicaltrials.gov/study/NCT07504198","title":"Neuroprotective Effect of Memantine and Rosuvastatin Against Oxaliplatin Induced Peripheral Neuropathy in Patients With Colorectal Cancer","has_exemption":false,"start_date":"2026-03-31","completion_date":"2027-04-30","has_results":false,"results_due":false,"sponsor_name":"Tanta University","sponsor_slug":"tanta-university","status":"ongoing","is_pact":false,"days_late":null}]}